Objective Owing to its unique configuration of two adjustable plate detectors positron emission mammography, or PEM, could theoretically also function as a high-resolution positron emission scanner for the extremities or neck. PEM quantitates its activity via a "PEM uptake value," or PUV, and although its relationship to the standardized uptake value, or SUV, has been demonstrated in the breasts, to our knowledge there are no studies validating PUV in other sites such as the extremities. Materials and methods This was a retrospective chart review of two separate protocols of a total of 15 patients. The patients all had hypermetabolic lesions in the extremities or neck on imaging with PET/CT and were sent after their PET/CT to PEM for further imaging. Owing to the sequential nature of these examinations no additional radiotracer was administered. Results Spearman's rank order correlation was calculated between the PUVmax obtained from PEM images, and the SUVmax for all. Spearman's rank order correlation for all sites was 0.42, which is not significantly different from 0 (p=0.13). When neck lesions were excluded from the group, there was a strong and statistically significant correlation between PUVmax and SUVmax, with Spearman's rank correlation of 0.73, and significantly different from 0 (p=0.0068). Discussion The correlation of PUVand SUV in the extremities indicates the potential use of PEM as a semiquantitative, highresolution positron emission scanner and warrants further investigation, especially in the realms of disease processes that often present in the extremities, such as melanoma, osteomyelitis, and arthritis, as well as playing a role in the imaging of patients with metallic hardware post-limb salvage surgery.
Introduction
Positron emission mammography, or PEM, was initially designed to overcome the limitations of conventional mammography [1] [2] [3] [4] [5] however its unique configuration lends itself to several potential uses. PEM was designed as a small portable device with two plate detectors, between which the site of interest is positioned. Like whole-body positron emission tomography, or WB PET, PEM utilizes the metabolism of F-18 FDG to demonstrate areas of hypermetabolism within the organ of interest. Also like WB PET/CT, PEM utilizes coincidence detection to help localize areas of increased radioactive tracer concentration within the breast. In order to provide a method of quantification, the manufacturers of PEM created the PUV, or PEM uptake value. Although the PUV, like SUV represents the activity concentration in the image, unlike the SUV, the calculation of PUV does not account for various data corrections such as attenuation or scattered photons [6] . Although the validity of the PUV as a quantification metric has not been well documented, a large single study published in the American Journal of Roentgenology [7] found a statistically significant correlation between SUV and PUV in the breast.
In theory the two adjustable arms of the PEM device may be positioned adjacent to any peripheral lesion. The superior spatial resolution of PEM [8] , combined with the possibility of using PUVas a surrogate for SUV, demonstrates a new role for PEM in the evaluation of small, difficult to image, peripherally located lesions. Our institution submitted a protocol for the use of PEM in the evaluation of small, superficially located malignancies. The primary malignancies of 15 patients were evaluated with PET/CT and PEM in order to demonstrate a relationship between PUVmax and SUVmax. We sought to demonstrate a correlation between these two values in order to evaluate the potential use of PUVmax as a validated surrogate for SUVmax in peripherally located malignancies.
Materials and methods
This study was approved by our institutional review board. Owing to the retrospective nature of this work, information was obtained via chart review (Table 1) . All of the patients who are part of this review had a biopsy-proven malignancy and underwent 18 F-FDG PET/CT as part of their evaluation. Immediately after their PET/CT, patients underwent imaging with PEM. Owing to the sequential nature of these examinations no additional F 18 FDG was administered.
PET/CT F-18 FDG was administered to the patients based on weight, with the administered activity in this patient group ranging from 325.6 to 495.8 MBq (8.8-13.4 mCi), with average administered activity of 418.1 MBq (11.3 mCi). Imaging was performed on an integrated PET/CT system (DSTe, RX, VCT, GE Medical Systems, Milwaukee, WI, USA) approximately 60-80 min after injection. Unenhanced CT was performed for attenuation correction and image registration. The extent of imaging was tailored to the indication, with inclusion of the extremities as needed (Fig. 1 ).
PEM
Positron emission mammography was performed following completion of PET/CT. The device used was a PEM Flex Solo II High Resolution PET (Naviscan, San Diego, CA, USA). PEM imaging was performed between 1.5 and 2 h after tracer administration. Since PEM images were obtained immediately after PET/CT imaging, no additional radiotracer was administered. The patient was seated in a comfortable position, and a trained technologist positioned the body part of interest between the two plate detectors of the PEM system. One of these detectors is fixed and provides stabilization, while the other adjusts for gentle compression of the body part being imaged. The positioning of these two plate detectors adjacent to the object of interest provides better spatial resolution and count sensitivity than with whole-body PET/CT [6] , with a reported in-plane resolution of 2 mm [9] . The use of two parallel plate detectors in PEM does not allow for true tomographic images. Instead, PEM must use a limited angle image reconstruction algorithm that employs 3D MELM, which results in 12 slices, representing the volume between the two detectors. The images were acquired as anterior or lateral. Limited angle reconstruction results in spatial anistropy, or the distortion of image geometry, particularly in the axial dimension (parallel to the two plate detectors); thus, the exact geometry of the lesions was not consistent from view to view.
Image analysis
Images from PET/CT were sent to an Advantage Windows AW reading station (GE, Milwaukee, WI, USA) where they were reviewed by an experienced reader. The lesion that had been previously seen on initial imaging or on biopsy was identified and an ROI was drawn to calculate its SUVmax (body weight calculation). The calculated SUV represents the ratio of concentration of the injected radiotracer activity within the ROI over the concentration of activity distributed throughout the body, normalized by body weight.
Images from PEM were sent to a work station using Naviscan's proprietary image analysis software. A board certified imager reviewed the 12 images for each view, selected the one with the best qualitative lesion to background ratio, and placed an ROI around the lesion. The software supplied a PUV. A PUV to background ratio, although recommended by the manufacturer, was not calculated owing to the varying anatomical locations of the images and inability to standardize backgrounds (Figs. 2, 3 ). 
Results
Spearman's rank order correlation was calculated between the PUVmax obtained from the frontal view and the SUVmax for all 15 patients. Spearman's rank order correlation between the PUVmax and SUVmax for the patients was 0.42, which is not significantly different from 0 (p=0.13).
During the data review, two distinct outliers were found: both neck lesions were found to have inconsistently low PUV values. When these results were excluded there was a strong and statistically significant correlation between PUVmax and SUVmax in the remaining 13 patients in the extremities group with Spearman's correlation of 0.73, which was significantly different from 0 (p=0.0068; Figs. 4, 5 ).
Discussion
The benefits of using metabolic imaging as both a diagnostic and predictive tool have been extensively extolled in the literature. The imaging modality of choice has been WB PET/CT. However, the fundamental limitation of WB PET/CT remains its difficulty in accurately characterizing the metabolic activity Fig. 3 The patient is a 21-yearold man with osteosarcoma of the ulna, which was resected days prior to imaging. The PET image depicted in a demonstrates linearappearing uptake, which most likely corresponds to soft tissue, but osseous activity cannot be excluded. The lateral PEM images in b and the anterior PEM image in c clearly depict hypermetabolic activity only within the soft tissue and tracking adjacent to the bone, consistent with post-surgical change Fig. 4 Maximum standardized uptake value (SUVmax) and maximum PEM uptake value (PUVmax) for all patients. The two significant outliers seen in the non-breast group represent patients with neck imaging of lesions smaller than 2.5 cm because of partial volume effects and smoothing [6] . The need for a new modality to accurately image and quantify the metabolic activity of lesions smaller than 2.5 cm is clear. PEM has been repeatedly shown to identify lesions smaller than those seen with WB PET/CT [9] ; yet, the validation of PEM as a means of semiquantitative assessment has been limited. There has only been a single series, published by Wang and colleagues, which addresses the validity of PUV in relation to SUV [7] . This study was performed on lesions in the breast and showed strong and statistically significant Spearman's correlation of 0.79 between PUV and SUV.
To our knowledge there have been no reports of the use of PEM to semiquantitatively evaluate the extremities or the neck, although the adjustable detector heads allow for such imaging. Broadening the application of the PEM beyond the breast to use PUVas a quantitative metric must address several new considerations, namely the lack of standardization or correction of the PEM uptake value. A phantom study found that quantitative accuracy of the PEM (based on the dose administered) was affected by the thickness of the phantom [10] . If this finding were reproducible in vivo, then we would see variations in the correlation between SUV and PUV in smaller objects of interest such as the hands versus larger objects such as the thigh. Although our sample size was too small to appreciate such differences in a statistically significant way, this finding would be interesting to evaluate in a larger study. In addition, factors such as lesion size, attenuation, and scatter have also been shown to affect the count density in PEM imaging, thereby influencing PUV [11] .
In theory, the variable attenuation characteristics of adjacent bone and tissue would have an impact on the accuracy of PUV compared with the relative lack of attenuating tissues in the breast, which could potentially explain the higher correlation of SUV and PUV in the breast in the Wang study versus the correlation seen in the extremities in our study. Despite the multiple factors influencing PUV accuracy, our study demonstrated that there was an overall correlation of PUVmax values with SUVmax in the extremities group, illustrating the potential of PUVmax to act as a surrogate for SUVmax in quantifying metabolic activity.
In our study PUVmax was measured on one view only per patient because positioning difficulties of the extremities prevented image acquisition from a second view in 4 patients. In addition, we chose to compare PUVmax directly with SUVmax without the use of a PUVmax-to-background ratio, as recommended by the manufacturer and performed by Wang et al.. This decision was made because of the heterogeneity of the disease sites, which would have led to significant inconsistency in background measurements.
The lack of correlation between PUV and SUV in the neck was conspicuous and although we had a paucity of patients for which to compare the extremities group (n=2). The rather suboptimal results seen in the neck were consistent with our understanding of PEM physics. The absence of correction for scatter with the PUV resulted in scatter from the adjacent brain and heart to decrease count sensitivity in the neck, thereby underestimating the PUV with a resultant lack of correlation with SUVmax for those lesions.
The use of PEM for high-resolution dedicated positron emission scanning that is able to provide a quantified value of activity for disease in the extremities has multiple potential implications for oncology. The use of the SUVmax both as a prognostic factor [12] and as an indicator of response to therapy in cancer imaging [13, 14] has been widely discussed in the literature. The results of our study show that PUV has the potential to act as an SUV surrogate and could in theory function as a prognostic factor or as an indicator of therapeutic response as well.
One scenario in which extremity imaging with PEM may be advantageous is in the assessment of peripherally located tumors, or lesions that are of a size below the threshold for reliable detection and/or characterization with PET/CT. An excellent example is a patient in this study who had a peripherally located melanoma, as seen in Fig. 1 . The lesion was seen in the medial aspect of the patient's surgical stump and measured <2.5 cm. The PEM images had significantly improved spatial resolution for this lesion, and the uptake was easily quantified by PUV measurement. Although there has been little published work on the evaluation of melanoma with high-resolution PET, there has been some preliminary research on uveal melanomas and high-resolution PET [15] . The use of high-resolution dedicated PET in the form of PEM warrants further investigation in melanoma research.
Positron emission mammography may also play a role in the imaging of the extremities after placement of metallic hardware in limb salvage surgeries. Although all metallic orthopedic hardware may theoretically heat up immediately prior to imaging, such hardware is generally safe to image using MRI. However, the imaging of the extremities with metallic hardware is problematic with beam hardening artifact seen on CT and field distortion and signal voids on MRI that can obscure the surgical site [16] . Hardware made out of ferromagnetic materials such as iron, cobalt, and nickel produces more artifacts on MRI than non-ferromagnetic material such as titanium and tantalum. Yet, on CT artifact is more proportional to the density of the metal hardware, making tantalum significantly more productive in terms of artifact than titanium [17] . MDCT and the several techniques, such as altering patient positioning on MRI, and using alternative sequences, such as fat suppression STIR, are currently used to image patients after limb salvage, providing an appreciable improvement in imaging [17] . PEM provides metabolic data with excellent spatial resolution without the impingement of metallic artifact. Although on PET/CT hypermetabolic activity may be seen in the bone adjacent to weight-bearing hardware because of increased osseous inflammation, one may presume that this level of activity would be lower and more diffuse than that of recurrent metabolically active disease. Several recent studies and case reports have reported abnormal or artifactual elevations of SUV when imaging patients with metallic prosthesis on PET/CT, but these were the results of attenuation correction artifact from the CT [18, 19] . Since PEM is not attenuation-corrected this should not be an issue.
The potential uses for PEM in the evaluation of the extremities extend beyond oncology and may include other fields in which high spatial resolutions are important, such as infectious disease and rheumatology. Preliminary studies evaluating the use of high-resolution PET in arthritis have already been published and a high-resolution PET scanner may fulfill some of the objectives of PET/MRI [20] . Of particular interest has been the potential usage of methyl-11 C-choline, a marker of cellular proliferation, to image the synovium in an effort to gauge active disease [21] . A recent study found that PET/CT was excellent at gauging response to therapy in joints affected by rheumatoid arthritis, but the results of smaller joints may have been inaccurate because of low resolution [22] , demonstrating the potential value of high-resolution positron emission imaging in rheumatoid arthritis therapy and monitoring.
To our knowledge, our study is the first to evaluate the validity of PUV in extremity imaging. By demonstrating the correlation between PUV and SUV in the extremities it opens the door to further investigation of the use of PEM as a highresolution imaging tool for use in small, peripherally located masses. The potential implications of such usage are vast, as multiple disease processes, such as melanoma and lung cancer, are often staged when the primary lesion is below the 2.5-cm threshold of SUVmax evaluation. As evidence grows that metabolic activity of primary lesions correlates with diseasefree survival in certain malignancies [23] the use of an SUV surrogate such as PUV becomes increasingly relevant.
